世界のIVIG市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV01860)
◆英語タイトル:Global IVIG Market Insights and Forecast to 2026
◆商品コード:QYR20NV01860
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:151
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはIVIGの世界市場について調査・分析した資料です。種類別(注射、凍結乾燥粉末)の市場規模、用途別(多発性硬化症(MS)、重症筋無力症(MG)、多巣性運動ニューロパチー(MMN)、多巣性後天性感覚運動ニューロパチー(MADSAM)、皮膚筋炎、多巣性運動ニューロシス)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別IVIGの競争状況、市場シェア
・世界のIVIG市場:種類別市場規模 2015年-2020年(注射、凍結乾燥粉末)
・世界のIVIG市場:種類別市場規模予測 2021年-2026年(注射、凍結乾燥粉末)
・世界のIVIG市場:用途別市場規模 2015年-2020年(多発性硬化症(MS)、重症筋無力症(MG)、多巣性運動ニューロパチー(MMN)、多巣性後天性感覚運動ニューロパチー(MADSAM)、皮膚筋炎、多巣性運動ニューロシス)
・世界のIVIG市場:用途別市場規模予測 2021年-2026年(多発性硬化症(MS)、重症筋無力症(MG)、多巣性運動ニューロパチー(MMN)、多巣性後天性感覚運動ニューロパチー(MADSAM)、皮膚筋炎、多巣性運動ニューロシス)
・北米のIVIG市場分析:米国、カナダ
・ヨーロッパのIVIG市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのIVIG市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のIVIG市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのIVIG市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Green Cross、BSV、Hualan Bio、RAAS、YUAN DA SHUYANG、Kangbao Bio、Tiantan Bio、Taibang Bio、Weiguang Bio、SIBP、TONROL、RUIDE Bio、BOYA Bio、RUIDE Bio、Xinxing Medicine、Weilun Bio、WIBP
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global IVIG Market
The global IVIG market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global IVIG Scope and Market Size
IVIG market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IVIG market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the IVIG market is segmented into
Injection
Lyophilized Powder

Segment by Application, the IVIG market is segmented into
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis

Regional and Country-level Analysis
The IVIG market is analysed and market size information is provided by regions (countries).
The key regions covered in the IVIG market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and IVIG Market Share Analysis
IVIG market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in IVIG business, the date to enter into the IVIG market, IVIG product introduction, recent developments, etc.

The major vendors covered:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP

【レポートの目次】

1 Study Coverage
1.1 IVIG Product Introduction
1.2 Market Segments
1.3 Key IVIG Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global IVIG Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Lyophilized Powder
1.5 Market by Application
1.5.1 Global IVIG Market Size Growth Rate by Application
1.5.2 Multiple Sclerosis (MS)
1.5.3 Myasthenia Gravis (MG)
1.5.4 Multifocal Motor Neuropathy (MMN)
1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
1.5.6 Dermatomyositis
1.5.7 Polymyositis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global IVIG Market Size, Estimates and Forecasts
2.1.1 Global IVIG Revenue 2015-2026
2.1.2 Global IVIG Sales 2015-2026
2.2 Global IVIG, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global IVIG Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global IVIG Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global IVIG Competitor Landscape by Players
3.1 IVIG Sales by Manufacturers
3.1.1 IVIG Sales by Manufacturers (2015-2020)
3.1.2 IVIG Sales Market Share by Manufacturers (2015-2020)
3.2 IVIG Revenue by Manufacturers
3.2.1 IVIG Revenue by Manufacturers (2015-2020)
3.2.2 IVIG Revenue Share by Manufacturers (2015-2020)
3.2.3 Global IVIG Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by IVIG Revenue in 2019
3.2.5 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 IVIG Price by Manufacturers
3.4 IVIG Manufacturing Base Distribution, Product Types
3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IVIG Product Type
3.4.3 Date of International Manufacturers Enter into IVIG Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global IVIG Market Size by Type (2015-2020)
4.1.1 Global IVIG Sales by Type (2015-2020)
4.1.2 Global IVIG Revenue by Type (2015-2020)
4.1.3 IVIG Average Selling Price (ASP) by Type (2015-2026)
4.2 Global IVIG Market Size Forecast by Type (2021-2026)
4.2.1 Global IVIG Sales Forecast by Type (2021-2026)
4.2.2 Global IVIG Revenue Forecast by Type (2021-2026)
4.2.3 IVIG Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global IVIG Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global IVIG Market Size by Application (2015-2020)
5.1.1 Global IVIG Sales by Application (2015-2020)
5.1.2 Global IVIG Revenue by Application (2015-2020)
5.1.3 IVIG Price by Application (2015-2020)
5.2 IVIG Market Size Forecast by Application (2021-2026)
5.2.1 Global IVIG Sales Forecast by Application (2021-2026)
5.2.2 Global IVIG Revenue Forecast by Application (2021-2026)
5.2.3 Global IVIG Price Forecast by Application (2021-2026)

6 North America
6.1 North America IVIG by Country
6.1.1 North America IVIG Sales by Country
6.1.2 North America IVIG Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America IVIG Market Facts & Figures by Type
6.3 North America IVIG Market Facts & Figures by Application

7 Europe
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country
7.1.2 Europe IVIG Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe IVIG Market Facts & Figures by Type
7.3 Europe IVIG Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific IVIG by Region
8.1.1 Asia Pacific IVIG Sales by Region
8.1.2 Asia Pacific IVIG Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific IVIG Market Facts & Figures by Type
8.3 Asia Pacific IVIG Market Facts & Figures by Application

9 Latin America
9.1 Latin America IVIG by Country
9.1.1 Latin America IVIG Sales by Country
9.1.2 Latin America IVIG Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America IVIG Market Facts & Figures by Type
9.3 Central & South America IVIG Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa IVIG by Country
10.1.1 Middle East and Africa IVIG Sales by Country
10.1.2 Middle East and Africa IVIG Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa IVIG Market Facts & Figures by Type
10.3 Middle East and Africa IVIG Market Facts & Figures by Application

11 Company Profiles
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.2 BSV
11.2.1 BSV Corporation Information
11.2.2 BSV Description and Business Overview
11.2.3 BSV Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BSV IVIG Products Offered
11.2.5 BSV Related Developments
11.3 Hualan Bio
11.3.1 Hualan Bio Corporation Information
11.3.2 Hualan Bio Description and Business Overview
11.3.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Hualan Bio IVIG Products Offered
11.3.5 Hualan Bio Related Developments
11.4 RAAS
11.4.1 RAAS Corporation Information
11.4.2 RAAS Description and Business Overview
11.4.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.4.4 RAAS IVIG Products Offered
11.4.5 RAAS Related Developments
11.5 YUAN DA SHUYANG
11.5.1 YUAN DA SHUYANG Corporation Information
11.5.2 YUAN DA SHUYANG Description and Business Overview
11.5.3 YUAN DA SHUYANG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 YUAN DA SHUYANG IVIG Products Offered
11.5.5 YUAN DA SHUYANG Related Developments
11.6 Kangbao Bio
11.6.1 Kangbao Bio Corporation Information
11.6.2 Kangbao Bio Description and Business Overview
11.6.3 Kangbao Bio Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Kangbao Bio IVIG Products Offered
11.6.5 Kangbao Bio Related Developments
11.7 Tiantan Bio
11.7.1 Tiantan Bio Corporation Information
11.7.2 Tiantan Bio Description and Business Overview
11.7.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Tiantan Bio IVIG Products Offered
11.7.5 Tiantan Bio Related Developments
11.8 Taibang Bio
11.8.1 Taibang Bio Corporation Information
11.8.2 Taibang Bio Description and Business Overview
11.8.3 Taibang Bio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taibang Bio IVIG Products Offered
11.8.5 Taibang Bio Related Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Corporation Information
11.9.2 Weiguang Bio Description and Business Overview
11.9.3 Weiguang Bio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Weiguang Bio IVIG Products Offered
11.9.5 Weiguang Bio Related Developments
11.10 SIBP
11.10.1 SIBP Corporation Information
11.10.2 SIBP Description and Business Overview
11.10.3 SIBP Sales, Revenue and Gross Margin (2015-2020)
11.10.4 SIBP IVIG Products Offered
11.10.5 SIBP Related Developments
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.12 RUIDE Bio
11.12.1 RUIDE Bio Corporation Information
11.12.2 RUIDE Bio Description and Business Overview
11.12.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.12.4 RUIDE Bio Products Offered
11.12.5 RUIDE Bio Related Developments
11.13 BOYA Bio
11.13.1 BOYA Bio Corporation Information
11.13.2 BOYA Bio Description and Business Overview
11.13.3 BOYA Bio Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BOYA Bio Products Offered
11.13.5 BOYA Bio Related Developments
11.14 RUIDE Bio
11.14.1 RUIDE Bio Corporation Information
11.14.2 RUIDE Bio Description and Business Overview
11.14.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.14.4 RUIDE Bio Products Offered
11.14.5 RUIDE Bio Related Developments
11.15 Xinxing Medicine
11.15.1 Xinxing Medicine Corporation Information
11.15.2 Xinxing Medicine Description and Business Overview
11.15.3 Xinxing Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Xinxing Medicine Products Offered
11.15.5 Xinxing Medicine Related Developments
11.16 Weilun Bio
11.16.1 Weilun Bio Corporation Information
11.16.2 Weilun Bio Description and Business Overview
11.16.3 Weilun Bio Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Weilun Bio Products Offered
11.16.5 Weilun Bio Related Developments
11.17 WIBP
11.17.1 WIBP Corporation Information
11.17.2 WIBP Description and Business Overview
11.17.3 WIBP Sales, Revenue and Gross Margin (2015-2020)
11.17.4 WIBP Products Offered
11.17.5 WIBP Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 IVIG Market Estimates and Projections by Region
12.1.1 Global IVIG Sales Forecast by Regions 2021-2026
12.1.2 Global IVIG Revenue Forecast by Regions 2021-2026
12.2 North America IVIG Market Size Forecast (2021-2026)
12.2.1 North America: IVIG Sales Forecast (2021-2026)
12.2.2 North America: IVIG Revenue Forecast (2021-2026)
12.2.3 North America: IVIG Market Size Forecast by Country (2021-2026)
12.3 Europe IVIG Market Size Forecast (2021-2026)
12.3.1 Europe: IVIG Sales Forecast (2021-2026)
12.3.2 Europe: IVIG Revenue Forecast (2021-2026)
12.3.3 Europe: IVIG Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific IVIG Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: IVIG Sales Forecast (2021-2026)
12.4.2 Asia Pacific: IVIG Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: IVIG Market Size Forecast by Region (2021-2026)
12.5 Latin America IVIG Market Size Forecast (2021-2026)
12.5.1 Latin America: IVIG Sales Forecast (2021-2026)
12.5.2 Latin America: IVIG Revenue Forecast (2021-2026)
12.5.3 Latin America: IVIG Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa IVIG Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: IVIG Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: IVIG Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: IVIG Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key IVIG Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IVIG Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Green Cross、BSV、Hualan Bio、RAAS、YUAN DA SHUYANG、Kangbao Bio、Tiantan Bio、Taibang Bio、Weiguang Bio、SIBP、TONROL、RUIDE Bio、BOYA Bio、RUIDE Bio、Xinxing Medicine、Weilun Bio、WIBP

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のIVIG市場2026:インサイト・予測(Global IVIG Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。